SUO 2019 neoadjuvant trials for localized high-risk prostate cancer, NHT+ARPI, optimal management for high-risk localized cancer, TAPS clinical trial, androgen deprivation therapy neoadjuvant trials
Oliver Sartor and Kambiz Rahbar discuss the RaLu study examining the safety and efficacy of sequential radiopharmaceutical treatments in metastatic castration-resistant prostate cancer. The discussion…
Diane Newman delivers a presentation on pelvic floor muscle rehabilitation following radical prostatectomy, highlighting the prevalence and impact of post-surgical urinary incontinence. She explained that…
SES AUA 2025 mental health diagnoses in testicular cancer survivors, mental health disorder, orchiectomy for testicular cancer, Truven Marketscan Commercial Claims and Encounters database.
SES AUA 2025, urologic workforce shortage, coping mechanisms for urologists, stress management for urologists.
Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: Neal…
Ruchika Talwar interviews David Morris about changes to Medicare Part D resulting from the Inflation Reduction Act. Dr. Morris discusses how these changes benefit prostate…
Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: Paul…
Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: A.…
Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: Alan…
Zachary Klaassen and Trinity Bivalacqua discuss sexual dysfunction following radical cystectomy, highlighting significant disparities in how these issues are addressed between male and female patients.…
